Favorable benefit–risk ratio with teriflunomide treatment in relapsing-remitting multiple sclerosis: Results of the 2-year, multicenter, prospective, noninterventional TAURUS MS st...

por Guger, Michael, Ackerl, Michael Matthias, Heine, Martin, Hofinger-Renner, Christiane, Spiss, Heinrich Karl, Taut, Andrea, Unger, Karin, Leutmezer, Fritz
Publicado 2022